Uncontested runway: the obstacles management narrates are execution and time, not rivals
The model's full reasoning — Q3 2018 call → NO我们根据提供的财报电话会议记录,判断管理层在解释当前业绩与更大业务量之间的差距时,所叙述的障碍是否主要是公司自身的执行和日程安排,而非其他卖家争夺同一需求。 分析:管理层讨论了多个产品,如Aimovig、Repatha、Prolia等,并提到了增长、市场份额、竞争等。但问题聚焦于:当管理层解释从当前结果到更大业务量的障碍时,是否叙述了自身的执行和日历(如建设、生产、招聘、培训、认证、安装、上线、开放、爬坡、转换、交付),而不是其他卖家竞争同一需求。 在记录中,管理层提到了: - Aimovig的强劲启动,但指出“随着我们解决初始需求激增,处方活动预计将在未来几周内缓和并正常化”,这涉及自身执行。 - Repatha的定价调整以改善可及性,但提到“尽管我们做出了改进,但太多患者面临高自付费用”,并提到“我们做出了重要决定”以降低价格,这涉及自身策略。 - 生物类似药如KANJINTI和AMGEVITA的推出,提到“我们正在推出”和“我们期待”等。 - 管线进展,如多个新项目进入临床。 但管理层也明确讨论了竞争,例如: - Neulasta面临生物类似药竞争,提到“我们观察到细分市场份额略有下降”和“我们预计会有更多生物类似药进入市场”。 - 在回答关于CGRP竞争的问题时,Murdo Gordon提到“我们相信我们能够与Aimovig的差异化产品特性竞争”,并提到“我们拥有先发优势”。 - 在回答关于PCSK9竞争时,提到“我们继续有效竞争,在美国PCSK9类别中占据领先份额62%”。 因此,管理层在叙述增长障碍时,确实提到了竞争因素,如市场份额、竞争产品、定价压力等。虽然也提到了自身执行(如爬坡、正常化),但整体上,管理层将增长视为在竞争环境中争夺需求,而非仅仅自身执行。 问题要求:当管理层解释当前结果与更大业务量之间的差距时,所叙述的障碍是否主要是自身执行和日历,而非其他卖家竞争同一需求?根据记录,管理层明确将竞争作为障碍之一,例如Neulasta的生物类似药竞争、CGRP市场的竞争等。因此,答案应为NO。 最终答案:NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| NOAH | Noah Holdings Limited | Q1 2024 | 2024-05-30 | D |
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| RCEL | AVITA Medical, Inc. | Q1 2024 | 2024-05-14 | F |
| ERO | Ero Copper Corp. | Q1 2024 | 2024-05-10 | A |
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| ECPG | Encore Capital Group, Inc. | Q1 2024 | 2024-05-08 | B |
| FWONK | Formula One Group | Q1 2024 | 2024-05-08 | C+ |
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| NC | NACCO Industries, Inc. | Q1 2024 | 2024-05-05 | C+ |
| PPC | Pilgrim's Pride Corporation | Q1 2024 | 2024-05-03 | A |
| CW | Curtiss-Wright Corporation | Q1 2024 | 2024-05-02 | B+ |
| TTI | TETRA Technologies, Inc. | Q1 2024 | 2024-05-01 | A |
| WEC | WEC Energy Group, Inc. | Q1 2024 | 2024-05-01 | A |
| ROCK | Gibraltar Industries, Inc. | Q1 2024 | 2024-05-01 | B+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| ASB | Associated Banc-Corp | Q1 2024 | 2024-04-25 | A |
| PDS | Precision Drilling Corporation | Q1 2024 | 2024-04-25 | B |
| GL | Globe Life Inc. | Q1 2024 | 2024-04-23 | F |
| CLGN | CollPlant Biotechnologies Ltd. | Q4 2023 | 2024-04-04 | F |
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| ASM | Avino Silver & Gold Mines Ltd. | Q4 2023 | 2024-03-21 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| PBR | Petróleo Brasileiro S.A. - Petrobras | Q4 2023 | 2024-03-08 | D |
| MNKD | MannKind Corporation | Q4 2023 | 2024-02-27 | C |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| EGP | EastGroup Properties, Inc. | Q4 2023 | 2024-02-08 | B |
| GPRO | GoPro, Inc. | Q4 2023 | 2024-02-07 | F |
| GPRE | Green Plains Inc. | Q4 2023 | 2024-02-07 | F |
| RDCM | RADCOM Ltd. | Q4 2023 | 2024-01-31 | A |
| HP | Helmerich & Payne, Inc. | Q1 2024 | 2024-01-30 | C |
| CHT | Chunghwa Telecom Co., Ltd. | Q4 2023 | 2024-01-30 | C |
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| CPRT | Copart, Inc. | Q1 2024 | 2023-11-16 | B+ |
| ICCM | IceCure Medical Ltd | Q3 2023 | 2023-11-15 | D |
| EFXT | Enerflex Ltd. | Q3 2023 | 2023-11-09 | C+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| MEG | Montrose Environmental Group, Inc. | Q3 2023 | 2023-11-08 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| CMPS | COMPASS Pathways plc | Q3 2023 | 2023-11-04 | F |
| GOLD | Barrick Gold Corporation | Q3 2023 | 2023-11-02 | C |
| AEP | American Electric Power Company, Inc. | Q3 2023 | 2023-11-02 | C+ |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| APAM | Artisan Partners Asset Management Inc. | Q3 2023 | 2023-11-01 | C+ |
| GRBK | Green Brick Partners, Inc. | Q3 2023 | 2023-11-01 | B |
| FSBC | Five Star Bancorp | Q3 2023 | 2023-10-31 | B |
| CMG | Chipotle Mexican Grill, Inc. | Q3 2023 | 2023-10-27 | B+ |
| ANGO | AngioDynamics, Inc. | Q1 2024 | 2023-10-04 | B |
| PTN | Palatin Technologies, Inc. | Q4 2023 | 2023-09-29 | D |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| BZUN | Baozun Inc. | Q2 2023 | 2023-08-28 | D |
| DXLG | Destination XL Group, Inc. | Q2 2023 | 2023-08-24 | D |
| KMDA | Kamada Ltd. | Q2 2023 | 2023-08-16 | B+ |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| TGLS | Tecnoglass Inc. | Q2 2023 | 2023-08-08 | A |
| HE | Hawaiian Electric Industries, Inc. | Q2 2023 | 2023-08-07 | C |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| PTLO | Portillo's Inc. | Q2 2023 | 2023-08-05 | B |
| ET | Energy Transfer LP | Q2 2023 | 2023-08-02 | C+ |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| CTO | CTO Realty Growth, Inc. | Q2 2023 | 2023-07-28 | B |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| IMAX | IMAX Corporation | Q2 2023 | 2023-07-26 | B+ |
| DAL | Delta Air Lines, Inc. | Q2 2023 | 2023-07-13 | A |
| GVP | GSE Systems, Inc. | Q1 2023 | 2023-05-15 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| GGR | Gogoro Inc. | Q1 2023 | 2023-05-11 | D |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SU | Suncor Energy Inc. | Q1 2023 | 2023-05-09 | C+ |
| SLDP | Solid Power, Inc. | Q1 2023 | 2023-05-08 | C+ |
| THS | TreeHouse Foods, Inc. | Q1 2023 | 2023-05-08 | B+ |
| ULCC | Frontier Group Holdings, Inc. | Q1 2023 | 2023-05-07 | C+ |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| SBRA | Sabra Health Care REIT, Inc. | Q1 2023 | 2023-05-04 | B |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| TSSI | TSS, Inc. | Q4 2022 | 2023-04-03 | D |
| BEAT | BioTelemetry's | Q4 2022 | 2023-03-17 | D |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| DKS | DICK'S Sporting Goods, Inc. | Q4 2022 | 2023-03-07 | B |
| M | Macy's, Inc. | Q4 2022 | 2023-03-02 | D |
| TGT | Target Corporation | Q4 2022 | 2023-02-28 | C |
| CRBG | Corebridge Financial, Inc. | Q4 2022 | 2023-02-22 | B |
| OEC | Orion Engineered Carbons S.A. | Q4 2022 | 2023-02-17 | B+ |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| HIW | Highwoods Properties, Inc. | Q4 2022 | 2023-02-08 | B |
| CEIX | CONSOL Energy Inc. | Q4 2022 | 2023-02-07 | B |
| UAL | United Airlines Holdings, Inc. | Q4 2022 | 2023-01-18 | B |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| ARWR | Arrowhead Pharmaceuticals, Inc. | Q4 2022 | 2022-11-28 | D |
| CIG | Companhia Energética de Minas Gerais | Q3 2022 | 2022-11-16 | C+ |
| CUE | Cue Biopharma, Inc. | Q3 2022 | 2022-11-14 | D |
| PKOH | Park-Ohio Holdings Corp. | Q3 2022 | 2022-11-13 | B |
| BLZE | Backblaze, Inc. | Q3 2022 | 2022-11-11 | D |
| CLSD | Clearside Biomedical, Inc. | Q3 2022 | 2022-11-09 | C |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| MEC | Mayville Engineering Company, Inc. | Q3 2022 | 2022-11-05 | B+ |
| CHE | Chemed Corporation | Q3 2022 | 2022-11-01 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| PKX | POSCO Holdings Inc. | Q3 2022 | 2022-10-24 | D |
| ASTS | AST SpaceMobile, Inc. | Q2 2022 | 2022-08-15 | D |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| IT | Gartner, Inc. | Q2 2022 | 2022-08-02 | A |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| LTBR | Lightbridge Corporation | Q2 2022 | 2022-07-28 | D |
| LIN | Linde plc | Q2 2022 | 2022-07-28 | B+ |
| JBHT | J.B. Hunt Transport Services, Inc. | Q2 2022 | 2022-07-19 | C+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| KFY | Korn Ferry | Q4 2022 | 2022-06-22 | B |
| SQM | Sociedad Química y Minera de Chile S.A. | Q1 2022 | 2022-05-19 | C+ |
| YALA | Yalla Group Limited | Q1 2022 | 2022-05-17 | C |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| WHF | WhiteHorse Finance, Inc. | Q1 2022 | 2022-05-10 | B+ |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| CCRN | Cross Country Healthcare, Inc. | Q1 2022 | 2022-05-04 | B |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| STC | Stewart Information Services Corporation | Q1 2022 | 2022-04-29 | C+ |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| ZENV | Zenvia Inc. | Q4 2021 | 2022-03-17 | C+ |
| SOPH | SOPHiA GENETICS SA | Q4 2021 | 2022-03-15 | C |
| HROW | Harrow Health, Inc. | Q4 2021 | 2022-03-10 | C |
| RELY | Remitly Global, Inc. | Q4 2021 | 2022-03-02 | B |
| KD | Kyndryl Holdings, Inc. | Q4 2021 | 2022-03-01 | C+ |
| AKAM | Akamai Technologies, Inc. | Q4 2021 | 2022-02-15 | B |
| FORM | FormFactor, Inc. | Q4 2021 | 2022-02-02 | B |
| FFIC | Flushing Financial Corporation | Q4 2021 | 2022-01-28 | B |
| HFWA | Heritage Financial Corporation | Q4 2021 | 2022-01-27 | A |
| EXP | Eagle Materials Inc. | Q3 2022 | 2022-01-27 | B |
| LC | LendingClub Corporation | Q4 2021 | 2022-01-26 | A |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| ZH | Zhihu Inc. | Q3 2021 | 2021-11-22 | D |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| LOW | Lowe's Companies, Inc. | Q3 2021 | 2021-11-17 | B+ |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
| CXW | CoreCivic, Inc. | Q3 2021 | 2021-11-09 | C |
| HNRG | Hallador Energy Company | Q3 2021 | 2021-11-09 | C+ |
| AKBA | Akebia Therapeutics, Inc. | Q3 2021 | 2021-11-09 | C+ |
| ALHC | Alignment Healthcare, Inc. | Q3 2021 | 2021-11-06 | B+ |
| KTB | Kontoor Brands, Inc. | Q3 2021 | 2021-11-04 | A |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| WMB | The Williams Companies, Inc. | Q3 2021 | 2021-11-02 | B |
| LMAT | LeMaitre Vascular, Inc. | Q3 2021 | 2021-10-29 | C+ |
| MD | Pediatrix Medical Group, Inc. | Q3 2021 | 2021-10-28 | B |
| FFWM | First Foundation Inc. | Q3 2021 | 2021-10-26 | B |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| TJX | The TJX Companies, Inc. | Q2 2021 | 2021-08-18 | C |
| EGY | VAALCO Energy, Inc. | Q2 2021 | 2021-08-12 | B |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| KNDI | Kandi Technologies Group, Inc. | Q2 2021 | 2021-08-09 | F |
| LOPE | Grand Canyon Education, Inc. | Q2 2021 | 2021-08-08 | C |
| GNK | Genco Shipping & Trading Limited | Q2 2021 | 2021-08-07 | A |
| UFI | Unifi, Inc. | Q4 2021 | 2021-08-07 | B |
| CLVT | Clarivate Plc | Q2 2021 | 2021-07-31 | B+ |
| AX | Axos Financial, Inc. | Q4 2021 | 2021-07-29 | C+ |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| TENB | Tenable Holdings, Inc. | Q2 2021 | 2021-07-27 | A |
| TCBI | Texas Capital Bancshares, Inc. | Q2 2021 | 2021-07-21 | F |
| ADSK | Autodesk, Inc. | Q3 2019 | 2018-11-20 | A |
| PRPO | Precipio, Inc. | Q3 2018 | 2018-11-19 | D |
| GECC | Great Elm Capital Corporation | Q3 2018 | 2018-11-13 | B |
| OGE | OGE Energy Corp. | Q3 2018 | 2018-11-08 | A |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| UMH | UMH Properties, Inc. | Q3 2018 | 2018-11-02 | C+ |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| CUBI | Customers Bancorp, Inc. | Q3 2018 | 2018-10-26 | C+ |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| STM | STMicroelectronics NV | Q3 2018 | 2018-10-24 | C+ |
| LRN | Stride, Inc. | Q1 2019 | 2018-10-23 | B |
| ALKS | Alkermes plc | Q3 2018 | 2018-10-23 | C |
| AU | AngloGold Ashanti's | Q2 2018 | 2018-08-20 | B |
| KOP | Koppers Holdings Inc. | Q2 2018 | 2018-08-12 | C+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| SO | The Southern Company | Q2 2018 | 2018-08-08 | D |
| SRDX | Surmodics, Inc. | Q3 2018 | 2018-08-06 | A |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| TMHC | Taylor Morrison Home Corporation | Q2 2018 | 2018-08-01 | B |
| FMS | Fresenius Medical Care AG & Co. KGaA | Q2 2018 | 2018-07-31 | C |
| XOM | Exxon Mobil Corporation | Q2 2018 | 2018-07-27 | C |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| CP | Canadian Pacific Railway Limited | Q2 2018 | 2018-07-19 | B+ |
| ASND | Ascendis Pharma A/S | Q1 2018 | 2018-05-30 | C+ |
| CLMT | Calumet Specialty Products Partners, L.P | Q1 2018 | 2018-05-16 | C+ |
| LAUR | Laureate Education, Inc. | Q1 2018 | 2018-05-13 | B+ |
| NOVT | Novanta Inc. | Q4 2017 | 2018-05-12 | B+ |
| FSS | Federal Signal Corporation | Q1 2018 | 2018-05-12 | A |
PPC · Q1 2024 → YESThe question is: On this call, when management explains what stands between the company's current results and a meaningfully larger amount of business, are the obstacles it actually narrates ITS OWN E...YES The transcript frames the path to more business as already underway through operational improvements (hatchability and livability gains), facility expansions in Mexico, and the startup of a protein conversion facility. Management describes these as practical steps—building, ramping, and qualifying capacity—that are in progress, directly addressing current limitations in 2023 results. Demand is tied to customer growth and industry tailwinds like protein switching, but the obstacles cited are internal execution and timing, not competitive battles. No emphasis is placed on winning deals against rivals or pricing strategies; instead, the focus remains on the company's own throughput and readiness.
EVBN · Q4 2016 → YESThe question is: On this call, when management explains what stands between the company's current results and a meaningfully larger amount of business, are the obstacles it actually narrates ITS OWN E...YES The transcript shows management narrating a real path to more business already in motion—market disruption from the KeyBank/First Niagara combination, organic capture, new branch openings, insurance agency acquisitions, core system conversions, hiring, and municipal banking department startup—with concrete operator-level work underway. The obstacles to scaling are framed as internal execution and calendar realities (18-24 month loan migration timelines, 9-month deposit ramps), not as demand being contested against rivals. While some competitive positioning language appears, it does not override the core account of growth limits as throughput and timing constraints rather than win-rate battles.
UPLD · Q4 2017 → YESThe question is: On this call, when management explains what stands between the company's current results and a meaningfully larger amount of business, are the obstacles it actually narrates ITS OWN E...NO The transcript centers on M&A-driven growth through acquisitions and integrations, with organic growth described as flat to 5% and not essential. Management frames the path to more business around building integration capabilities, hiring, training, qualifying, and ramping operations post-acquisition, which aligns with execution and calendar constraints. However the discussion includes competitive elements such as replacing incumbents and displacing rivals in some cases, which introduces a contest for demand. Additionally, the narrative emphasizes the company's own readiness and pipeline rather than purely external factors, but the competitive mentions prevent a clean YES under the criteria.